A recent meta-analysis based on eleven human clinical trials (involving a total of 388 subjects) indicated that resveratrol supplementation could significantly reduce fasting glucose, insulin, hemoglobin A1c, and insulin resistance levels in participants with diabetes, but no significant impact on glycemic parameters was recorded in nondiabetic participants [4]. Here, INS is linked to Insulin resistance.